Investing Profile

Albert Cha

InvestorVC

Managing Partner at VIVO Capital

Your Intro Paths to Albert Cha

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Albert is a member of

Hotmail Network

4890 CONNECTIONS

Stanford University Network

923 CONNECTIONS

Oracle Network

169 CONNECTIONS

University of California, Los Angeles Network

158 CONNECTIONS

VIVO Capital Network

11 CONNECTIONS

Find Albert Cha on

Current Investing Position

Vivo Capital Managing Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$1.4B

Albert Cha is on these Sector & Stage Rankings

Albert Cha's Investments On Record (13)

Company	StageDateRound Size	Total Raised
Egetis Therapeutics	Post Ipo EquityApr 2026$38M Post Ipo EquityOct 2023$16M	$54M
Scorpion Therapeutics	Series CJul 2024$150M	$420M
Co-investors: Paulina Hill (Polaris Partners), Jean-François Formela (Atlas Venture), Arjun Goyal (Vida Ventures)
Silence Therapeutics	Post Ipo EquityNov 2021$20M	$20M
Olema Oncology	Series COct 2020$85M	$85M
AirXpanders	Post Ipo EquitySep 2018$15M Series ESep 2014$1M Series EJun 2013$9M Series DApr 2012$11M Series DJan 2012$10M	$46M
Bristol-Myers Squibb	Post Ipo EquityFeb 2017$80M	$80M
Co-investors: Peter Kolchinsky (RA Capital), Eric Aguiar (Aisling Capital), Gregory Bailey
Aclaris Therapeutics	Series CSep 2015$40M Series BOct 2014$21M Series AOct 2012$21M	$82M
Co-investors: Ketan Patel (F-Prime Capital Partners)
Sierra Oncology	Series DApr 2014$60M	$60M
Co-investors: Peter Thompson (OrbiMed), James N. Topper (Xelas Consulting LLC)